Stock Earnings

Question 1

What are Sino Biopharmaceutical Limited's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Sino Biopharmaceutical Limited has a total asset of $65,408, Net profit of $3,499

Question 2

What are the key financial ratios for SBHMY?

Accepted Answer

Sino Biopharmaceutical Limited's Current ratio is 1.95, has a Net margin is 12.12, sales per share of $1.57.

Question 3

How is Sino Biopharmaceutical Limited's revenue broken down by segment or geography?

Accepted Answer

Sino Biopharmaceutical Limited largest revenue segment is Modernised Chinese Medicines and Chemical Medicines, at a revenue of 30,858,886,510 in the most earnings release.For geography, China is the primary market for Sino Biopharmaceutical Limited, at a revenue of 31,297,379,178.

Question 4

Is Sino Biopharmaceutical Limited profitable?

Accepted Answer

yes, according to the latest financial statements, Sino Biopharmaceutical Limited has a net profit of $3,499

Question 5

Does Sino Biopharmaceutical Limited have any liabilities?

Accepted Answer

yes, Sino Biopharmaceutical Limited has liability of 33,447

Question 6

How many outstanding shares for Sino Biopharmaceutical Limited?

Accepted Answer

Sino Biopharmaceutical Limited has a total outstanding shares of 17,924.16

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	30,566	28,866	26,199	26,026	26,861	23,647
Revenue Growth (YoY)	14%	10%	1%	-3%	14%	-2%
Cost of Revenue	5,572	5,336	4,989	4,487	5,332	5,182
Gross Profit	24,994	23,529	21,209	21,538	21,529	18,464
Selling, General & Admin	12,854	12,159	11,066	11,708	12,763	11,628
Research & Development	5,698	5,089	4,402	4,164	3,677	2,626
Operating Expenses	19,705	17,437	15,263	15,845	16,749	14,093
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	7,630	5,277	5,409	5,214	18,572	5,013
Income Tax Expense	860	492	797	696	1,957	672
Net Income	3,871	3,499	2,331	2,543	14,608	2,771
Net Income Growth	-5%	50%	-8%	-83%	426.99%	0%
Shares Outstanding (Diluted)	18,025.87	18,295.06	18,529.06	19,017.2	19,282.95	18,800.28
Shares Change (YoY)	-2%	-1%	-3%	-1%	3%	0%
EPS (Diluted)	0.21	0.19	0.12	0.13	0.75	0.14
EPS Growth	-2%	57.99%	-8%	-83%	409%	0%
Free Cash Flow	5,873	5,655	4,997	5,021	3,652	3,830
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	81.77%	81.51%	80.95%	82.75%	80.14%	78.08%
Operating Margin	17.3%	21.1%	22.69%	21.87%	17.79%	18.48%
Profit Margin	12.66%	12.12%	8.89%	9.77%	54.38%	11.71%
Free Cash Flow Margin	19.21%	19.59%	19.07%	19.29%	13.59%	16.19%
EBITDA	--	7,384	6,992	6,699	5,750	5,981
EBITDA Margin	--	25.58%	26.68%	25.73%	21.4%	25.29%
D&A For EBITDA	--	1,292	1,047	1,007	971	1,610
EBIT	5,288	6,092	5,945	5,692	4,779	4,371
EBIT Margin	17.3%	21.1%	22.69%	21.87%	17.79%	18.48%
Effective Tax Rate	11.27%	9.32%	14.73%	13.34%	10.53%	13.4%

Sino Biopharmaceutical Limited (SBHMY) Financial

SBHMY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Sino Biopharmaceutical Ltd.?

SBHMY Income

Follow-Up Questions